IQVIA™ Real-World Insights Bibliography

Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors].
Author(s): Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2
Affiliations(s): 1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense
Publication(s):  Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris
Document Type(s): Poster,
Countries: France,
C:
Y:
Diabetes, Endocrinology, Metabolic Disorders ,
2014
  L:
A:
French
Retrospective database analysis,
  Add to report
 
 
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010
Author(s): Jewett PI, Gangnon RE, Trentham-Dietz A, Sprague BL
Affiliations(s): University of Wisconsin
Publication(s):  Obstet Gynecol 2014;124(4):727-733.
Document Type(s): Abstract,
Countries: 
Click here for the abstract
C:
Y:
Endocrinology,
2014
  L:
A:
English
Real World Evidence,
  Add to report
 
 
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers.
Author(s): Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC.
Affiliations(s): Novo Nordsik; IMS authors: Divino V
Publication(s):  J Pediatr Nurs
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Endocrinology,
2013
  L:
A:
English
Survey research,
  Add to report
 
 
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers.
Author(s): Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC.
Affiliations(s): Novo Nordsik; IMS authors: Divino V
Publication(s):  J Pediatr Nurs
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Endocrinology,
2013
  L:
A:
English
Survey research,
  Add to report
 
 
Improvements in Health-Related Quality of life in Acromegaly with Pasireotide LAR and Octreotide LAR: Results from a large, randomized, Double-Blind Phase III Trial
Author(s): Badia X1, Forsythe A2, Nelson LM3, Coles TM3, McLeod LD3, Webb SM4
Affiliations(s): 1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3RTI Health Solutions, Research Triangle Park, NC, USA, 4Hospital Sant Pau and CIBERER 747, Universitat Autònoma de Barcelona, Barcelona, Spain
Publication(s):  ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Type(s): Poster,
Countries: Spain,
Click here for the abstract
C:
Y:
Endocrinology,
2012
  L:
A:
English
Prospective study,
  Add to report
 
 
Chart Audit and Budget impact analysis of Pasireotide versus second-line therapies in the treatment of Cushing´s disease in Germany
Author(s): Badia X1, Forsythe A2, Stemmer V3, Cummins G4
Affiliations(s): 1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3Novartis Pharma GmbH, Nuremberg, Germany, 4Quintiles Consulting, Hawthorne, NY, USA
Publication(s):  ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Type(s): Poster,
Countries: Germany,
Click here for the abstract
C:
Y:
Endocrinology,
2012
  L:
A:
English
Budget impact,
  Add to report
 
 
Psychometric performance of the CushingQol questionnaire in conditions of real clinical practice.
Author(s): Santos A, Resmini E, Martínez-Momblán MªA, Crespo I, Valassi E, Roset M, Badia X, Webb S.
Affiliations(s): Health Economics and Outcomes Research, IMS Health, Barcelona, Hospital Sant Pau, Center of Biomedical Investigation in rare diseases.
Publication(s):  Eur J Endocrinol. 2012 Sep;167(3):337-42
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Endocrinology,
2012
  L:
A:
English
Quality of life,
  Add to report
 
 
Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing?s syndrome: cohort study.
Author(s): Fardet L, Petersen I & Nazareth I.
Affiliations(s): UCL MRC General Practice Research Framework
Publication(s):  BMJ2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4928(Published 30 July 2012)
BMJ: 345:e4928
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Endocrinology,
2012
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care.
Author(s): Fardet L, Petersen I & Nazareth I
Affiliations(s): Medical Research Council General Practice Research Framework
Publication(s):  Am J Psychiatry. 2012 May;169(5):491-7.
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Endocrinology, Mental health,
2012
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Severe hypertriglyceridaemia in patients treated with lipid-modifying agents.
Author(s): Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4.
Affiliations(s): 1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4Université de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France
Publication(s):  Diabetes & Metabolism Volume 38, n° 3 pages 277-279 (juin 2012)
Document Type(s): Article,
Countries: Belgium, France, Germany, Italy, UK,
Click here for the abstract
C:
Y:
Endocrinology, Metabolic Disorders , Vascular disease,
2012
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
First Page Previous Page  2 of 5 Next Page Last Page